Active Ingredient History
A zoster vaccine is a vaccine that reduces the incidence of herpes zoster (shingles), a disease caused by reactivation of the varicella zoster virus, which is also responsible for chickenpox. Shingles provokes a painful rash with blisters, and can be followed by chronic pain, as well as other complications. Older people are more often affected, as are people with weakened immune systems (immunosuppression). Both shingles and postherpetic neuralgia can be prevented by vaccination. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Herpes Zoster Vaccine (approved 2017)
Allergy and Immunology (Early Phase 1)
Arthritis, Rheumatoid (Phase 4)
Chickenpox (Phase 2/Phase 3)
Colitis, Ulcerative (Phase 4)
Coronavirus Infections (Early Phase 1)
Crohn Disease (Phase 4)
Healthy Volunteers (Phase 4)
Herpesvirus 3, Human (Phase 4)
Herpes Zoster (Phase 4)
Herpes Zoster Vaccine (Phase 2)
HIV Infections (Phase 4)
Immunosuppression Therapy (Phase 2/Phase 3)
Inflammatory Bowel Diseases (Phase 4)
Injection Site Reaction (Phase 4)
Kidney Transplantation (Phase 4)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Liver Diseases (Phase 2/Phase 3)
Lung Diseases (Phase 2)
Neuroblastoma (Phase 1)
Osteosarcoma (Phase 1)
Pain (Phase 4)
Quality of Life (Phase 4)
Varicella Zoster Virus Infection (Phase 4)
Waldenstrom Macroglobulinemia (Early Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
